PT

Philip E. Thorpe

University Of Texas System: 57 patents #2 of 6,559Top 1%
SR Scripps Research: 5 patents #168 of 1,293Top 15%
TR The Universty Of Texas System,Board Of Regents: 2 patents #4 of 109Top 4%
PP Peregrine Pharmaceuticals: 2 patents #4 of 17Top 25%
UT University Of Texas: 1 patents #37 of 278Top 15%
IT Imperial Cancer Research Technology: 1 patents #35 of 66Top 55%
📍 London, TX: #2 of 86 inventorsTop 3%
Overall (All Time): #33,007 of 4,157,543Top 1%
66
Patents All Time

Issued Patents All Time

Showing 26–50 of 66 patents

Patent #TitleCo-InventorsDate
7384909 Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents M. Melina Soares, Jin He 2008-06-10
7378386 Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives M. Melina Soares, Jin He 2008-05-27
7247303 Selected antibody CDRs for binding to aminophospholipids Sophia Ran 2007-07-24
7125541 Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy Francis Burrows 2006-10-24
7112317 Combined methods and compositions for tumor vasculature targeting and tumor treatment Francis Burrows 2006-09-26
7101557 Combined tissue factor methods for coagulation and tumor treatment Steven W. King, Boning Gao 2006-09-05
7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids Sophia Ran, Rolf A. Brekken 2006-06-27
7056509 Antibody methods for selectively inhibiting VEGF Rolf A. Brekken 2006-06-06
6887468 Antibody kits for selectively inhibiting VEGF Rolf A. Brekken 2005-05-03
6818213 Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids Sophia Ran, Rolf A. Brekken 2004-11-16
6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids Sophia Ran, Rolf A. Brekken 2004-08-31
6749853 Combined methods and compositions for coagulation and tumor treatment Thomas S. Edgington 2004-06-15
6703020 Antibody conjugate methods for selectively inhibiting VEGF Rolf A. Brekken 2004-03-09
6676941 Antibody conjugate formulations for selectively inhibiting VEGF Rolf A. Brekken 2004-01-13
6524583 Antibody methods for selectively inhibiting VEGF Rolf A. Brekken 2003-02-25
6451312 VEGF-gelonin for targeting the vasculature of solid tumors 2002-09-17
6416758 Antibody conjugate kits for selectively inhibiting VEGF Rolf A. Brekken 2002-07-09
6406693 Cancer treatment methods using antibodies to aminophospholipids Sophia Ran 2002-06-18
6342221 Antibody conjugate compositions for selectively inhibiting VEGF Rolf A. Brekken 2002-01-29
6342219 Antibody compositions for selectively inhibiting VEGF Rolf A. Brekken 2002-01-29
6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids Sophia Ran 2001-11-06
6261535 Diagnostic methods for targeting the vasculature of solid tumors Francis Burrows 2001-07-17
6156321 Tissue factor methods and compositions for coagulation and tumor treatment Steven W. King, Boning Gao 2000-12-05
6132729 Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment Steven W. King, Boning Gao 2000-10-17
6132730 Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment Steven W. King, Boning Gao 2000-10-17